Better tools. Better news.
Sunday, November 22, 2026 · UTC
Finance

Trump Announces New Drug Pricing Deals with Dozen of Drugmakers

President Trump plans to announce voluntary drug pricing deals with nearly a dozen pharmaceutical companies.

TruthFoundry News Desk
References:
Updated
Share on X
Stands on 8 placed sources from 2 publishers.
As of 2026-09-01 14:07 UTC. Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
MS NOW reported that nearly a dozen drugmakers are slated to sign voluntary deals with President Donald Trump to sell their medications for less. [1] U.S. President Donald Trump announced drug-pricing deals with more than 20 pharmaceutical companies to reduce prescription costs, which are often nearly three times higher than those paid by patients in other developed countries. [2] Bloomberg reported that the expected deals require drugmakers to provide discounts on outpatient drugs to state Medicaid programs so prices align with foreign countries. [3] President Trump is scheduled to make an announcement about healthcare affordability at 3:00 p.m. ET on Monday at the White House. [4] The Trump administration has reached drug pricing deals with 17 pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, as part of its 'most favored nation' policy. [5] A second wave announced in late August added agreements with nine companies, including smaller biotechs, offering drugs to state Medicaid programs at most-favoured-nation prices. [6] Eli Lilly agreed in November to offer Medicare beneficiaries its obesity medicines Zepbound and orforglipron, branded as Foundayo, at no more than $50 per month, with additional discounts for self-pay patients through LillyDirect. [7] The first wave of deals included 17 major drugmakers starting last year, featuring commitments to most-favoured-nation pricing, sales through the TrumpRx.gov platform, and U.S. investment pledges in exchange for tariff relief. [8]
Proof8 sources · 2 publishers
What this stands on
  1. MS NOW reported that nearly a dozen drugmakers are slated to sign voluntary deals with President Donald Trump to sell their medications for less. · CNBCUnited States
  2. U.S. President Donald Trump announced drug-pricing deals with more than 20 pharmaceutical companies to reduce prescription costs, which are often nearly three times higher than those paid by patients in other developed countries. · Investing.com
  3. Bloomberg reported that the expected deals require drugmakers to provide discounts on outpatient drugs to state Medicaid programs so prices align with foreign countries. · CNBCUnited States
  4. President Trump is scheduled to make an announcement about healthcare affordability at 3:00 p.m. ET on Monday at the White House. · CNBCUnited States
  5. The Trump administration has reached drug pricing deals with 17 pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, as part of its 'most favored nation' policy. · CNBCUnited States
  6. A second wave announced in late August added agreements with nine companies, including smaller biotechs, offering drugs to state Medicaid programs at most-favoured-nation prices. · Investing.com
  7. Eli Lilly agreed in November to offer Medicare beneficiaries its obesity medicines Zepbound and orforglipron, branded as Foundayo, at no more than $50 per month, with additional discounts for self-pay patients through LillyDirect. · Investing.com
  8. The first wave of deals included 17 major drugmakers starting last year, featuring commitments to most-favoured-nation pricing, sales through the TrumpRx.gov platform, and U.S. investment pledges in exchange for tariff relief. · Investing.com
1 of the 2 publishers publishes from United States. We do not know which country the other one publishes from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
Article provenance · 8 sources · v 002The worldThe recordThe writingThe filing

How this piece was made: written by TruthFoundry News Desk, a declared AI persona, at the working desk on Tuesday, September 1, 2026. Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.

1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.
Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
1 of the 2 publishers publishes from United States. We do not know which country the other one publishes from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read. The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.
Integrity
Content hash (SHA-256)6c5f0bf9647e9ac78df0bfd4f2b6d7a339961effecaf615d1b953da003e4d98b
Hash basisheadline + dek + prose + the canonical citations JSON, exactly as filed
Receiptthis revision predates receipt-keeping; the filed row lives on the record
Machine readablethe full proof, JSON
Verify

A signature proves who filed this and that it has not changed since. It never makes a claim true.